UK's Judges Scientific prelim FY25 revenue grows, raises dividend

Judges Scientific

31/03/2026 07:18

Overview

UK scientific instrument group's preliminary FY25 revenue rose 9% yr/yr

Adjusted basic EPS fell 3% as US research funding cuts hit order intake

Company raised total dividend 10% despite challenging trading conditions

Outlook

Judges Scientific expects 2026 adjusted EPS in the range of 200p-250p

Company says 2026 YTD order intake is 17% below 2025 YTD comparative

Result Drivers

US RESEARCH FUNDING UNCERTAINTY - Co said a sharp reduction in US order intake, its largest market, due to uncertainties around federal funding for scientific research was the major feature of FY25 trading

INDUSTRIAL SECTOR SOFTNESS - Co noted reduced investments in offshore wind and batteries, and ongoing cyclicality in telecoms, contributed to weaker demand in some end markets

Company press release: ID:nRSe7124Ya

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
FY Revenue
GBP 145.80 mln


Analyst Coverage

The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the industrial machinery & equipment peer group is "buy."

Wall Street's median 12-month price target for Judges Scientific PLC is GBp7,000.00, about 74.1% above its March 30 closing price of GBp4,020.00

The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 18 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)